Skip to content

A Study Comparing the Differences Between Young and Non-young Breast Cancer

A Study Comparing the Differences Between Young and Non-young Breast Cancer

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06793306
Enrollment
3000
Registered
2025-01-27
Start date
2025-01-01
Completion date
2030-01-31
Last updated
2025-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

To collect data on diagnosis, treatment, survival prognosis, and intrinsic molecular detection of breast cancer in China from January 2000 to December 2024.Compare the difference between young and non-young breast cancer.

Interventions

OTHERAge

Breast cancer patients were divided into young breast cancer and non-young breast cancer by age 35

OTHERcombination therapy

To observe and compare the difference in diagnosis, combined treatment and prognosis between young and non-young breast cancer

Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* During the period from January 2000 to December 2024, the first breast cancer diagnosed and treated in several hospitals in China was in the age range of 18-75 years.

Exclusion criteria

* Breast cancer patients under 18 years of age or over 75 years of age; Combined with other malignant tumors; Patients with chronic infectious diseases or chronic infectious diseases; Patients with severe comorbidities, with serious dysfunction of vital organs (heart, liver, kidney); Known history of human immunodeficiency virus; The investigator concluded that patients should not be included in other conditions of this trial.

Design outcomes

Primary

MeasureTime frame
Overall survival rate10-year

Secondary

MeasureTime frame
invasive disease-free survival rate10-year

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026